BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bockstal V, Tiemessen MM, Achterberg R, Van Wordragen C, Knaapen AM, Serroyen J, Marissen WE, Schuitemaker H, Zahn R. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model. Vaccine 2018;36:6979-87. [PMID: 30314910 DOI: 10.1016/j.vaccine.2018.09.068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Leroux-Roels I, Leroux-Roels G, Shukarev G, Schuitemaker H, Cahill C, de Rooij R, Struijs M, van Zeeburg H, Jacquet JM. Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults. Hum Vaccin Immunother 2021;17:1366-73. [PMID: 33175637 DOI: 10.1080/21645515.2020.1812315] [Reference Citation Analysis]
2 Donadei A, Kraan H, Ophorst O, Flynn O, O'Mahony C, Soema PC, Moore AC. Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies. J Control Release 2019;311-312:96-103. [PMID: 31484041 DOI: 10.1016/j.jconrel.2019.08.039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
3 Abd-Elghaffar AA, Rashed ME, Ali AE, Amin MA. In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine. Vaccines (Basel) 2020;8:E601. [PMID: 33066050 DOI: 10.3390/vaccines8040601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]